Novonesis and Novo Nordisk to explore new solutions to improve metabolic health (DKK 409.70, 0.00)
Novonesis downgraded to hold from buy at Danske Bank (DKK 390.00, 0.00)
StreetAccount Summary - Trading higher/lower: EU mid-morning
StreetAccount Metrics Recap - Novonesis Q2 Earnings (DKK 419.20, 0.00)
StreetAccount Consensus Metrics Preview - Novonesis Q2 Earnings (DKK 416.20, +1.00)
StreetAccount Summary: EU stocks reaching new 52-week highs/lows (74 total)
Powered by FactSet Research Systems Inc.